Viridian Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Viridian Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Viridian Therapeutics Inc
Rating: 0.88140275
Author: Trendlyne DVM scores

Momentum Trap

about

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligr...

18.56 0.53 (2.94%)

45.87% Fall from 52W High

2.2M

XNAS Volume

XNAS 20 Jul, 2026 5:30 PM (EDT)

Low Financial Strength

11.1 / 100

Expensive Valuation

11.0 / 100

Technically Neutral

37.3 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 95%

16 analysts

Viridian Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Viridian Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligr...

45.87% Fall from 52W High

SWOT Analysis

Viridian Therapeutics Inc Live Price Chart

Viridian Therapeutics Inc Live Price Chart